Guo and colleagues the expression profiles of CAR-T target antigens (CD33, IL3RA, and CLEC12A) at a single-cell level, and found significant upregulation of CD33 and IL3RA compared to normal BM HSPC and CLEC12A was strongly positive in almost all AML samples (74). Here, CLEC12A is linked to acute myeloid leukemia.